BMP9/ALK1 inhibits neovascularization in mouse models of agerelated macular degeneration

Document Type

Article

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in aging populations of industrialized countries. The drawbacks of inhibitors of vascular endothelial growth factor (VEGFs) currently used for the treatment of AMD, which include resistance and potential serious side-effects, require the identification of new therapeutic targets to modulate angiogenesis. BMP9 signaling through the endothelial Alk1 serine-threonine kinase receptor modulates the response of endothelial cells to VEGF and promotes vessel quiescence and maturation during development. Here, we show that BMP9/Alk1 signaling inhibits neovessel formation in mouse models of pathological ocular angiogenesis relevant to AMD. Activating Alk1 signaling in laser-induced choroidal neovascularization (CNV) and oxygen-induced retinopathy (OIR) inhibited neovascularization and reduced the volume of vascular lesions. Alk1 signaling was also found to interfere with VEGF signaling in endothelial cells whereas BMP9 potentiated the inhibitory effects of VEGFR2 signaling blockade, both in OIR and laser-induced CNV. Together, our data show that targeting BMP9/Alk1 efficiently prevents the growth of neovessels in AMD models and introduce a new approach to improve conventional anti-VEGF therapies.

Keywords

Age-related macular degeneration, Angiogenesis, BMP signaling, Ocular pathologies

Publication Date

1-1-2016

Publication Title

Oncotarget

E-ISSN

19492553

Volume

7

Issue

35

First Page

55957

Last Page

55969

PubMed ID

27517154

Digital Object Identifier (DOI)

10.18632/oncotarget.11182

Link to Full Text

Share

COinS